VivoSeq
Other

Plantar Wart

18

Pipeline Programs

6

Active Trials

6

Companies Involved

Plantar Wart is an emerging landscape with 18 programs across 6 companies. The most active players are Aurobindo Pharma Ltd, Nowarta Biopharma Inc, Pfizer. 5 therapies are approved with 4 more in late-stage development.

Pipeline Metrics

Competitive Density

46/100

Pipeline Velocity

15/100

Mech. Concentration

20/100

Completion Rate

60/100

Attrition Rate

10/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

20

clinical trials

Unknown status9 · 45%
Recruiting3 · 15%
Completed3 · 15%
Not yet recruiting2 · 10%
Terminated1 · 5%
Withdrawn1 · 5%
Other1 · 5%

Trial Activity

20 trials

Intralesional Vitamin D Versus Intralesional Acyclovir in Plantar Warts
Not yet recruiting··Phase 4·NCT07196670·60 enrolled
Studying of Natural Constituents' Treatment of Plantar Warts
Completed··Phase 1·NCT05592041·20 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)